2,251
Views
69
CrossRef citations to date
0
Altmetric
Review Article

Hydroxocobalamin in cyanide poisoning

&
Pages 875-885 | Received 29 Aug 2012, Accepted 16 Oct 2012, Published online: 19 Nov 2012

References

  • Randaccio L, Geremia S, Demitri N, Wuerges J. Vitamin B12: unique metalorganic compounds and the most complex vitamins. Molecules 2010; 15:3228–3259.
  • Léonard A, Lauwerys R. Mutagenicity, carcinogenicity and teratogenicity of cobalt metal and cobalt compounds. Mutat Res 1990; 239:17–27.
  • Lauwerys R, Lison D. Health risks associated with cobalt exposure–an overview. Sci Total Environ 1994; 150:1–6.
  • Catalani S, Rizzetti MC, Padovani A, Apostoli P. Neurotoxicity of cobalt. Hum Exp Toxicol 2012; 31:421–437.
  • Paulet G. L’Intoxication Cyanhydrique et son Traitement. Paris: Masson SA, 1960.
  • Schiff M, Benoist J-F, Tilea B, Royer N, Giraudier S, Ogier de Baulny H. Isolated remethylation disorders: do our treatments benefit patients?J Inherit Metab Dis 2011; 34:137–145.
  • European Medicines Agency A. Summary of the European public assessment report (EPAR). Cyanokit. [Online] 2012. Available at: http://www.ema.europa.eu/ema/index.jsp?curl = pages/medicines/human/medicines/000806/human_med_000731.jsp&mid =WC0b01 ac058001d124. Accessed on 3 Jul 2012.
  • Astier A, Baud FJ. Simultaneous determination of hydroxocobalamin and its cyanide complex cyanocobalamin in human plasma by high-performance liquid chromatography. Application to pharmacokinetic studies after high-dose hydroxocobalamin as an antidote for severe cyanide poisoning. J Chromatogr B Biomed Appl 1995; 667:129–135.
  • Houeto P, Buneaux F, Galliot-Guilley M, Baud FJ, Levillain P. Determination of hydroxocobalamin and cyanocobalamin by derivative spectrophotometry in cyanide poisoning. J Anal Toxicol 1994; 18:154–158.
  • de la Coussaye JE, Houeto P, Sandouk P, Levillain P, Sassine A, Riou B. Pharmacokinetics of hydroxocobalamin in dogs. J Neurosurg Anesthesiol 1994; 6:111–115.
  • Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, Hall AH. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993; 31:277–294.
  • Houeto P, Borron SW, Sandouk P, Imbert M, Levillain P, Baud FJ. Pharmacokinetics of hydroxocobalamin in smoke inhalation victims. J Toxicol Clin Toxicol 1996; 34:397–404.
  • Riou B, Baud FJ, Astier A, Barriot P, Lecarpentier Y. In vitrodemonstration of the antidotal efficacy of hydroxocobalamin in cyanide poisoning. J Neurosurg Anesthesiol 1990; 2:296–304.
  • Astier A, Baud FJ. Complexation of intracellular cyanide by hydroxocobalamin using a human cellular model. Hum Exp Toxicol 1996; 15:19–25.
  • Mushett CW, Kelley KL, Boxer GE, Rickards JC. Antidotal efficacy of vitamin B12a(hydroxocobalamin) in experimental cyanide poisoning. Proc Soc Exp Biol Med 1952; 81:234–237.
  • Evans CL. Cobalt compounds as antidotes for hydrocyanic acid. Br J Pharmacol 1964; 23:455–475.
  • Posner MA, Tobey RE, McElroy H. Hydroxocobalamin therapy of cyanide intoxication in guinea pigs. Anesthesiology 1976; 44:157–160.
  • Rose CL, Worth RM, Chen KK. Hydroxo-cobalamine and acute cyanide poisoning in dogs. Life Sci 1965; 4:1785–1789.
  • Borron SW, Stonerook M, Reid F. Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol 2006; 44:5–15.
  • Hatch RC, Laflamme DP, Jain AV. Effects of various known and potential cyanide antagonists and a glutathione depletor on acute toxicity of cyanide in mice. Vet Hum Toxicol 1990; 32:9–16.
  • Chan A, Balasubramanian M, Blackledge W, Mohammad OM, Alvarez L, Boss GR, Bigby TD. Cobinamide is superior to other treatments in a mouse model of cyanide poisoning. Clin Toxicol 2010; 48:709–717.
  • Lawson-Smith P, Olsen NV, Hyldegaard O. Hyperbaric oxygen therapy or hydroxycobalamin attenuates surges in brain interstitial lactate and glucose; and hyperbaric oxygen improves respiratory status in cyanide-intoxicated rats. Undersea Hyperb Med 2011; 38:223–237.
  • Mengel K, Krämer W, Isert B, Friedberg KD. Thiosulphate and hydroxocobalamin prophylaxis in progressive cyanide poisoning in guinea-pigs. Toxicology 1989; 54:335–342.
  • Brenner M, Mahon SB, Lee J, Kim J, Mukai D, Goodman S, . Comparison of cobinamide to hydroxocobalamin in reversing cyanide physiologic effects in rabbits using diffuse optical spectroscopy monitoring. J Biomed Opt 2010; 15:017001.
  • Bebarta VS, Tanen DA, Lairet J, Dixon PS, Valtier S, Bush A. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med 2010; 55:345–351.
  • Jang DH, Nelson LS, Hoffman RS. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in acute cyanide toxicity. Ann Emerg Med 2010; 55:582.
  • Bebarta VS, Tanen DA, Lairet J, Dixon PS. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in acute cyanide toxicity – in reply. Ann Emerg Med 2010; 55:582–583.
  • Bebarta VS, Pitotti RL, Dixon PS, Valtier S, Esquivel L, Bush A, Little CM. Hydroxocobalamin and epinephrine both improve survival in a swine model of cyanide-induced cardiac arrest. Ann Emerg Med 2012; online early: doi:10.1016/j.annemergmed.2012.02.002.
  • Bebarta VS, Pitotti RL, Dixon P, Lairet JR, Bush A, Tanen DA. Hydroxocobalamin versus sodium thiosulfate for the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med 2012; 59:532–539.
  • Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med 2007; 25:551–558.
  • Coentrão L, Moura D. Acute cyanide poisoning among jewelry and textile industry workers. Am J Emerg Med 2011; 29:78–81.
  • Payen C, Combe C, Le Meur C, Gaillard Y, Pulce C, Descotes J. Lethal acute poisoning with potassium ferrocyanide. Am J Emerg Med 2010; 28:642.
  • Lutier F, Dusoleil P, de Montgros J. Action de l’hydroxocobalamine à dose massive dans l’intoxication aiguë au cyanure. (A propos d’un cas). Arch Mal Prof 1971; 32:683–686.
  • Tassan H, Joyon D, Richard T, Lamaison D, Guelon D, Barakeh S. [Potassium cyanide poisoning treated with hydroxocobalamin]. Ann Fr Anesth Réanim 1990; 9:383–385.
  • Mannaioni G, Vannacci A, Marzocca C, Zorn AM, Peruzzi S, Moroni F. Acute cyanide intoxication treated with a combination of hydroxocobalamin, sodium nitrite, and sodium thiosulfate. J Toxicol Clin Toxicol 2002; 40:181–183.
  • Hon KL, Cheung KL. Pink toes and red urine: what is this poison?Hong Kong Med J 2010; 16:411–412.
  • Erdman AR. Reply to: “Is hydroxocobalamin safe and effective for smoke inhalation? searching for guidance in the haze” - in reply. Ann Emerg Med 2008; 51:110–111.
  • Alarie Y. Toxicity of fire smoke. Crit Rev Toxicol 2002; 32:259–289.
  • Wing KS, Cheung CY, Lung LF. Hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2008; 51:108.
  • Dueñas-Laita A, Burillo Putze G, Alonso JR, Bajo A, Climent B, Corral E, . Bases del manejo clinico de la intoxicacion por humo de incendios < Docohumo Madrid 2010><>. Med Intensiva 2010; 34:609–619.
  • Breton D, Jouvet P, de BJ, Delacourt C, Hubert P.[Toxicity of fire smoke. Apropos of 2 pediatric cases]. Arch Fr Pediatr 1993; 50: 43–45.
  • Houeto P, Hoffman JR, Imbert M, Levillain P, Baud FJ. Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning. Lancet 1995; 346:605–608.
  • Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2007; 49:794–801.
  • Desola J. Hydroxycobalamin, hyperbaric oxygen and cyanide poisoning. Undersea Hyperb Med 2011; 38:217–220.
  • Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol 2006; 44:37–44.
  • Fortin JL, Capellier G, Manzon C, Giocanti J, Gall O. Intraosseous administration of hydroxocobalamin in the acute treatment of cyanide poisoning. Burns 2009; 35 Suppl 1:S15–S16.
  • Fortin JL, Judic-Peureux V, Desmettre T, Manzon C, Grimon D, Hostalek U, . Hydrogen cyanide poisoning in a prison environment: a case report. J Correct Health Care 2011; 17:29–33.
  • Fortin J-L, Desmettre T, Manzon C, Judic-Peureux V, Peugeot- Mortier C, Giocanti J-P, . Cyanide poisoning and cardiac disorders: 161 cases. J Emerg Med 2010; 38:467–476.
  • Roderique EJ, Gebre-Giorgis AA, Stewart DH, Feldman MJ, Pozez AL. Smoke inhalation injury in a pregnant patient: a literature review of the evidence and current best practices in the setting of a classic case. J Burn Care Res 2012;33:624–633.
  • Ballantyne B. Chemical terrorism. In: Ballantyne B, Marrs T, Syversen T, eds. General and Applied Toxicology. 3rd ed. Chichester, UK: John Wiley & Sons; 2009; 2923–2946.
  • Bryson D. Acute industrial cyanide intoxication and its treatment. In: Ballantyne B, Marrs TC, eds. Clinical and Experimental Toxicology of Cyanides. Bristol, UK: Wright, IOP Publishing; 1987; 348–358.
  • Erdman AR. Is hydroxocobalamin safe and effective for inhalation? Searching for guidance in the haze. Ann Emerg Med 2007; 49: 814–816.
  • Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med 2001; 37:635–641.
  • Keim ME. Terrorism involving cyanide: the prospect of improving preparedness in the prehospital setting. Prehosp Disaster Med 2006; 21:s56–s60.
  • National Cancer Institute. Questions and answers about laetrile/amygdalin. [Online] 2010. Available at: http://www.cancer.gov/cancertopics/pdq/cam/laetrile/patient/allpages#Section_20
  • Akyildiz BN, Kurtoglu S, Kondolot M, Tunc A. Cyanide poisoning caused by ingestion of apricot seeds. Ann Trop Paediatr 2010; 30: 39–43.
  • Cigolini D, Ricci G, Zannoni M, Codogni R, De Luca M, Perfetti P, Rocca G. Hydroxocobalamin treatment of acute cyanide poisoning from apricot kernels. Emerg Med J 2011; 28:804–805.
  • Zerbe NF, Wagner BK. Use of vitamin B12 in the treatment and prevention of nitroprusside-induced cyanide toxicity. Crit Care Med 1993; 21:465–467.
  • Bismuth C, Baud FJ, Pontal PG. Hydroxocobalamin in chronic cyanide poisoning. J Toxicol Clin Exp 1988; 8:35–38.
  • Beregi JP, Riou B, Lecarpentier Y. Effects of hydroxocobalamin on rat cardiac papillary muscle. Intensive Care Med 1991; 17:175–177.
  • Riou B, Gérard J-L, La Rochelle CD, Bourdon R, Berdeaux A, Giudicelli J-F. Hemodynamic effects of hydroxocobalamin in conscious dogs. Anesthesiology 1991; 74:552–558.
  • Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 1993; 19:26–32.
  • Pery-Man N, Houeto P, Coirault C, Suard I, Perennec J, Riou B, Lecarpentier Y. Hydroxocobalamin vs cobalt toxicity on rat cardiac and diaphragmatic muscles. Intensive Care Med 1996; 22:108–115.
  • Curry SC, Connor DA, Raschke RA. Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med 1994; 24:65–67.
  • Hudson M, Cashin BV, Matlock AG, Kang C, Wills BK. A man with purple urine. Clin Toxicol 2012; 50:77.
  • Torremade Barreda J, Serrallach Orejas M, Valles-Ortega J, Franco Miranda E. Treatment with hydroxocobalamin for cyanide poisoning: a rare cause of pseudohematuria. Actas Urol Esp 2010; 34:124–126.
  • Sutter M, Tereshchenko N, Rafii R, Daubert GP. Hemodialysis complications of hydroxocobalamin: a case report. J Med Toxicol 2010; 6:165–167.
  • Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol 2006; 44:17–28.
  • Høvding G. Anaphylactic reaction after injection of vitamin B12. Br Med J 1968; 3:102.
  • Dally S, Gaultier M. [Anaphylactic shock caused by hydroxocobalamin]. Nouv Presse Med 1976; 5:1917.
  • Uqwu CN, Qibbins FJ. Anaphylactic reaction to vitamin B12appearing after several years of therapy. Age Ageing 1981; 10:196–97.
  • James J, Warin RP. Sensitivity to cyanocobalamin and hydroxocobalamin. Br Med J 1971; 2:262.
  • PevnyI, Hartmann A, Metz J. [Vitamin B 12-(cyanocobalamin)- allergy]. Hautarzt 1977; 28:600–603.
  • Vidal C, Lorenzo A. Anaphylactoid reaction to hydroxycobalamin with tolerance of cyanocobalamin. Postgrad Med J 1998; 74:702.
  • Bilwani F, Adil SN, Sheikh U, Humera A, Khurshid M. Anaphylactic reaction after intramuscular injection of cyanocobalamin (vitamin B12): a case report. J Pak Med Assoc 2005; 55:217–219.
  • Moloney FJ, Hughes R, O’Shea D, Kirby B. Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin. Clin Exp Dermatol 2008; 33:412–414.
  • Branco-Ferreira M, Clode MH, Pereira-Barbosa MA, Palma-Carlos AG. Anaphylactic reaction to hydroxycobalamin. Allergy 1997; 52: 118–119.
  • Tordjman R, Genereau T, Guinnepain M-T, Weyer A, Lortholary O, Royer I, . Reintroduction of vitamin B12in 2 patients with prior B12-induced anaphylaxis. Eur J Haematol 1998; 60:269–270.
  • Djuric V, Bogic M, Popadic AP, Spiric VT, Raskovic S. Anaphylactic reaction to hydroxycobalamin with tolerance to cyanocobalamin. Ann Allergy Asthma Immunol 2012; 108:207–208.
  • Gourlain H, Caliez C, Laforge M, Buneaux F, Levillain P. Study of the mechanisms involved in hydroxocobalamin interference with determination of some biochemical parameters. Ann Biol Clin 1994; 52:121–124.
  • Vest P, Renaudeau C, Tellal S, Ragot C, Renard C. [Interference of hydroxocobalamine treatment on commun biochemical determinations]. Ann Biol Clin 2002; 60:57–64.
  • Lee J, Mukai D, Kreuter K, Mahon S, Tromberg B, Brenner M. Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments. Ann Emerg Med 2007; 49:802–805.
  • Carlsson CJ, Hansen HE, Hilsted L, Malm J, Ødum L, Szecsi PB. An evaluation of the interference of hydroxycobalamin with chemistry and co-oximetry tests on nine commonly used instruments. Scand J Clin Lab Invest 2011; 71:378–386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.